Clinical Trial: Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Linvemastat in Patients With Partially Controlled Asthma

U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07191535) titled 'Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Linvemastat in Patients With Partially Controlled Asthma' on Sept. 17.

Brief Summary: This study explores a potential new treatment for adults with moderate-to-severe asthma using a drug called linvemastat, which targets an enzyme linked to lung inflammation. Despite using standard asthma medications, many patients still struggle with symptoms, so researchers are testing whether linvemastat can improve lung function and reduce flare-ups. In a carefully controlled trial, participants receive either one of two doses of the drug or a placebo, while continuing...